Last reviewed · How we verify

NCT04821154

Persona Revision Knee System Outcomes

Recruiting now Last updated 24 October 2025
What this trial tests

trial testing Persona Revision Knee System in Arthroplasty Complications in 380 participants. Currently enrolling.

Timeline
14 June 2021
Primary endpoint
31 December 2027
31 December 2027

Quick facts

Lead sponsorZimmer Biomet
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment380
Start date14 June 2021
Primary completion31 December 2027
Estimated completion31 December 2027
Sites16 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Zimmer Biomet — full company profile →

Who can join

18 and older, any sex, with Arthroplasty Complications or Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study will evaluate the performance, clinical benefits and safety of the Persona Revision Knee System in patients who have received primary or revision total knee arthroplasty (TKA) treatment. This will be done using a multicenter, single-arm, consecutive series, retrospective cohort study with prospective follow-up.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Arthroplasty Complications

Currently open trials in the same condition.

Other Zimmer Biomet trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04821154.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing